1-5 of 5
Yuanfei Shi
Close
Sort by
Journal Articles

Real Event Analysis of the Efficacy and Safety of Polatuzumab Vedotin Combination Regimen in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Yuanfei Shi, Yi Xu, Jinghan Wang, Xiaolong Zheng, Xueying Li, Jie Jin, Hongyan Tong, Wanzhuo Xie
Journal: Blood
Blood (2023) 142 (Supplement 1): 6100.
https://doi.org/10.1182/blood-2023-186156
Published: 2023
Journal Articles

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Jianai Sun, Yi Xu, Yuanfei Shi, Jinghan Wang, Xueying Li, Xiaolong Zheng, Wen-Juan Yu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood
Blood (2023) 142 (Supplement 1): 6224.
https://doi.org/10.1182/blood-2023-186591
Published: 2023
Journal Articles

The Prognostic Value of Common Cardiovascular Biomarkers in the Survival of Patients with DLBCL

Yi Xu, Yuanfei Shi, Jianai Sun, Xiaolong Zheng, Xueying Li, Jinghan Wang, Wenjuan Yu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood
Blood (2023) 142 (Supplement 1): 6306.
https://doi.org/10.1182/blood-2023-186066
Published: 2023
Journal Articles

Low-Dose Triptolide Enhances Bromodomain Inhibitor JQ1-Induced Apoptosis of Acute Myeloid Leukemia Cells Via Down-Regulation of c-Myc Following RAS/MEK/ERK Inhibition

Bing Xu, Yuanfei Shi, Haijun Zhao, Yi Qiu, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5757.
https://doi.org/10.1182/blood-2019-123740
Published: 2019
Journal Articles

Combination of BCL-2 Inhibition and Triptolide Causes Synthetic Lethality in Acute Myeloid Leukemia through Preventing Reciprocal Resistance

Bing Xu, Yuanfei Shi, Long Liu, Bing Z Carter, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2083.
https://doi.org/10.1182/blood-2019-123722
Published: 2019